|
US5110977A
(en)
|
1990-02-14 |
1992-05-05 |
Eastman Kodak Company |
Ester-containing quaternary ammonium salts as adhesion improving toner charge agents
|
|
US20030083272A1
(en)
|
1997-09-19 |
2003-05-01 |
Lahive & Cockfield, Llp |
Sense mrna therapy
|
|
AU2009238175C1
(en)
|
2008-04-15 |
2023-11-30 |
Arbutus Biopharma Corporation |
Novel lipid formulations for nucleic acid delivery
|
|
KR102451116B1
(ko)
|
2011-10-27 |
2022-10-06 |
메사추세츠 인스티튜트 오브 테크놀로지 |
약물 캡슐화 마이크로스피어를 형성할 수 있는, ｎ-말단 상에 관능화된 아미노산 유도체
|
|
EP3608308B1
(en)
|
2013-03-08 |
2021-07-21 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
EP4019506A1
(en)
|
2013-12-19 |
2022-06-29 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
ES2895651T3
(es)
|
2013-12-19 |
2022-02-22 |
Novartis Ag |
Lípidos y composiciones lipídicas para la administración de agentes activos
|
|
US10125092B2
(en)
|
2014-09-05 |
2018-11-13 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
DK3297637T3
(da)
*
|
2015-05-21 |
2021-08-02 |
Ohio State Innovation Foundation |
Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
|
|
EP4286012A3
(en)
|
2015-09-17 |
2024-05-29 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したＣａｓ９蛋白質
|
|
KR102547316B1
(ko)
|
2016-08-03 |
2023-06-23 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
WO2019008441A1
(en)
|
2017-07-04 |
2019-01-10 |
Intocell, Inc. |
COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF
|
|
EP3704262B1
(en)
|
2017-10-30 |
2024-03-20 |
Georgia Tech Research Corporation |
Multiplexed analysis of materials for tissue delivery
|
|
WO2019099501A1
(en)
|
2017-11-14 |
2019-05-23 |
Ohio State Innovation Foundation |
Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof
|
|
WO2020072605A1
(en)
|
2018-10-02 |
2020-04-09 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids
|
|
IL314386A
(en)
|
2018-12-05 |
2024-09-01 |
Intellia Therapeutics Inc |
amine modified lipids
|
|
JP7636330B2
(ja)
|
2019-01-17 |
2025-02-26 |
ジョージア テック リサーチ コーポレイション |
酸化コレステロールを含有する薬物送達システム
|
|
KR20210139265A
(ko)
|
2019-02-13 |
2021-11-22 |
빔 테라퓨틱스, 인크. |
표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법
|
|
WO2020219876A1
(en)
|
2019-04-25 |
2020-10-29 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
CN114144173A
(zh)
|
2019-06-05 |
2022-03-04 |
盖德治疗公司 |
用于组织递送的材料的分析
|
|
US12569438B2
(en)
|
2019-07-29 |
2026-03-10 |
Georgia Tech Research Corporation |
Nanomaterials containing constrained lipids and uses thereof
|
|
US20220259597A1
(en)
|
2019-07-29 |
2022-08-18 |
Georgia Tech Research Corporation |
Oligonucleotide antagonists for rna guided genome editing
|
|
JP7699128B2
(ja)
|
2019-12-06 |
2025-06-26 |
ガイド セラピューティクス，エルエルシー |
ナノマテリアル
|
|
US12435035B2
(en)
|
2020-01-09 |
2025-10-07 |
Guide Therapeutics, Llc |
Nanomaterials
|
|
MX2023007137A
(es)
|
2020-12-21 |
2023-08-28 |
Beam Therapeutics Inc |
Nanomateriales que comprenden acetales unidos a ésteres.
|
|
CN116782913A
(zh)
|
2020-12-21 |
2023-09-19 |
比姆医疗股份有限公司 |
包括缩醛的纳米材料
|
|
WO2022140239A1
(en)
|
2020-12-21 |
2022-06-30 |
Beam Therapeutics Inc. |
Nanomaterials comprising carbonates
|
|
IL303845A
(en)
|
2021-01-20 |
2023-08-01 |
Beam Therapeutics Inc |
Nanomaterials include a degradable property
|
|
JP2024503441A
(ja)
|
2021-01-20 |
2024-01-25 |
ビーム セラピューティクス インク． |
イオン化可能な脂質を含むナノ材料
|
|
AU2022210299A1
(en)
|
2021-01-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable lipids for nanomaterials
|
|
KR20230131863A
(ko)
|
2021-01-20 |
2023-09-14 |
빔 테라퓨틱스, 인크. |
나노물질
|
|
CA3241488A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
EP4452930A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Ionizable amine and ester lipids and lipid nanoparticles
|
|
EP4452925A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterial comprising diamines
|
|
EP4452942A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterials comprising disulfides
|
|
WO2023121971A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterials comprising tetravalent lipid compounds
|